T1	Pharmacological_substance 28 39	pravastatin
N1000 	Reference T1 MeSH:D017035	pravastatin
T2	Disorder 130 139	depressed
N1 	Reference T2 UMLS:C0344315	depressed
T3	Pharmacological_substance 260 275	antidepressants
N1001 	Reference T3 MeSH:D000928	antidepressants
T4	Pharmacological_substance 277 305	atypical antipsychotic drugs
T5	Pharmacological_substance 327 334	lithium
N1002 	Reference T5 MeSH:D008094	lithium
T6	Pharmacological_substance 363 374	pravastatin
N1003 	Reference T6 MeSH:D017035	pravastatin
T7	Disorder 380 389	skin rash
N2 	Reference T7 UMLS:C0015230	skin rash
T8	Pharmacological_substance 438 448	olanzapine
N1004 	Reference T8 MeSH:C076029	olanzapine
T9	Pharmacological_substance 515 526	pravastatin
N1005 	Reference T9 MeSH:D017035	pravastatin
T12	Pharmacological_substance 602 609	lithium
N1006 	Reference T12 MeSH:D008094	lithium
T13	Disorder 626 643	allergic reaction
N3 	Reference T13 UMLS:C1527304	allergic reaction
N4 	Reference T13 UMLS:C0020517	allergic reaction
T14	Pharmacological_substance 690 701	pravastatin
N1007 	Reference T14 MeSH:D017035	pravastatin
T15	Pharmacological_substance 733 756	atypical antipsychotics
T16	Pharmacological_substance 762 769	statins
N1008 	Reference T16 MeSH:D019161	statins
T11	Pharmacological_substance 0 15	Mood stabilizer
T18	Disorder 57 79	adverse skin reactions
T19	Speculation_cue 48 52	risk
T20	Subject 140 157	55-year-old woman
T21	Disorder 176 208	erythematous pigmented skin rash
T22	Combination 233 244	combination
T23	Pharmacological_substance 311 326	mood stabilizer
T24	Pharmacological_substance 343 362	lipid-lowering drug
N1009 	Reference T24 MeSH:D000960	lipid-lowering drug
T29	Speculation_cue 406 414	probably
T30	Combination 598 601	and
T35	Combination 718 729	combination
T33	Combination 24 27	and
T36	Manner_cue 41 47	higher
